Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses - Test2 - elhamkhani - TriplyDB

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

http://www.wikidata.org/entity/Q29618915

about

Restructuring consciousness -the psychedelic state in light of integrated information theory Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission Early-stage visual processing and cortical amplification deficits in schizophrenia.Open channel block and alteration of N-methyl-D-aspartic acid receptor gating by an analog of phencyclidine.Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia Microbiota and Neurological Disorders: A Gut Feeling.GABAergic interneuron origin of schizophrenia pathophysiology.Probing GABA receptor function in schizophrenia with iomazenil Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study Cannabis and psychosis/schizophrenia: human studies Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Neurophysiological and computational principles of cortical rhythms in cognition Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.To use or not to use: an update on licit and illicit ketamine use Neural synchrony in schizophrenia: from networks to new treatments Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia Ketamine: review of its pharmacology and its use in pediatric anesthesia Animal models of schizophrenia: a critical review Investigation of the potentiation of the analgesic effects of fentanyl by ketamine in humans: a double-blinded, randomised, placebo controlled, crossover study of experimental pain[ISRCTN83088383]Defects of the Glycinergic Synapse in Zebrafish.Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials The dysconnection hypothesis (2016)Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy MicroRNAs: Not "Fine-Tuners" but Key Regulators of Neuronal Development and Function Auditory dysfunction in schizophrenia: integrating clinical and basic features.Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target Legal highs: staying on top of the flood of novel psychoactive substances Preclinical models of antipsychotic drug action.High-frequency oscillations and the neurobiology of schizophrenia

P2860

Q21129375-02CF1A1B-278A-4B7E-B2EA-7FC95511CED8 Q22241226-D66CC678-BC50-4963-BF86-E19A307352B0 Q22241430-1A5F040E-9E31-4A80-8CA3-3760F33D0EE3 Q22241679-0EFBE1F4-DA6C-4B12-81B7-B46090B8C013 Q23913269-00D287CB-C047-469A-878D-CF6A23D26733 Q24536566-CB953E46-0698-4BF2-BB7E-30F29926D713 Q24537274-CA95A348-2A91-45EA-B8A2-8DA79486D16B Q24562939-5CC5B67D-A95F-45FE-BFB2-1930ADE6BC98 Q24570085-2A45DFD1-D263-4D66-8A93-6A5C6E6EFCD4 Q24597790-824F2394-16E8-4465-B64C-6F154EFD76AF Q24601700-3BE9847A-FA2A-4396-B99D-D0A6EF75DD90 Q24602550-7ABF7363-8C40-4398-96B0-03060599E2AF Q24606088-2A61E4E6-55E0-41D4-A7B6-4322963CF7DE Q24612550-9499F9B6-7861-413E-843C-8388C3BE85D3 Q24614608-FA753442-9884-47D3-B839-BA6745BA2952 Q24620536-4536DFD2-4D41-4274-9FC4-6661EB3EFFFC Q24627766-D909BA04-49C7-46E9-A4D3-CDFD4130C489 Q24628837-B2F93E4A-A6A6-4D78-BBC1-EC961A182493 Q24629398-43F1F4A3-8D89-465A-8876-176E706468EC Q24630153-EBACA9E3-F008-4E22-901B-7655276B1F85 Q24630528-6B531885-D717-427D-BE6A-4FAFC1912F7A Q24631189-BB9797F7-674F-415F-8117-83A0B2817CAF Q24634006-FF9AA926-A30C-4C53-AFF5-9B1C5A818D68 Q24644168-16E9D2F4-0FF4-482C-A5EF-E4AE8AEB4B31 Q24646206-AED0301E-01AF-42CE-A934-CCDC0B748EAE Q24649621-3F520C35-1FA2-472D-8E3A-008998411386 Q24669627-6EDC4B09-A6DA-4396-8C70-449B66D3869C Q24674909-E6F7360A-A418-4E35-844C-35DF1D2FED3E Q24791277-11D591B0-7A05-4B30-9847-77758D87D548 Q26738425-F70EAC7D-0743-4988-A22C-3E8731441218 Q26741541-361BEF14-C9BA-46B1-B191-BF5EA2A93600 Q26741916-0089A9AB-B8F6-48ED-AA0A-031AC4650030 Q26750021-57EFD34F-FA8C-4A31-BAD8-E2A6133F475E Q26773084-ED8B478D-1F10-460E-A03A-133C1158EF38 Q26774739-EDE48D8B-0614-4781-97B6-BA9473CD17F8 Q26796401-300B3AF7-AE93-4335-A26D-FAF5C4426811 Q26798948-0C348188-87B5-4F77-A071-5555B473CABA Q26799231-9BD71B5A-0F99-4B2D-82EE-225AD1673930 Q26827502-A6465B22-F325-4EF4-8CAA-C90233ECC6D7 Q26829587-8A5C3D3C-DDE6-49B5-B0D5-5B9FB71F543B

P2860

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

http://www.wikidata.org/entity/Q29618915

description

1994 nî lūn-bûn

@nan

1994 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի մարտին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Subanesthetic effects of the n ...... , and neuroendocrine responses

@ast

Subanesthetic effects of the n ...... , and neuroendocrine responses

@en

type

label

Subanesthetic effects of the n ...... , and neuroendocrine responses

@ast

Subanesthetic effects of the n ...... , and neuroendocrine responses

@en

prefLabel

Subanesthetic effects of the n ...... , and neuroendocrine responses

@ast

Subanesthetic effects of the n ...... , and neuroendocrine responses

@en

P1433

Q29618915-5719D3FD-DF99-4D51-AB74-A0968C06B201

P1476

Q29618915-CAA3899F-07A3-425E-A9CA-7FDEE11FB90B

P2093

Q29618915-4223D09B-A286-4483-8F43-39C71B3FDC7A

Q29618915-47F43A7E-02D3-4600-B836-704185B4911D

Q29618915-482DB06B-6969-40A9-B219-21D9CEE8DB7B

Q29618915-4C3C2028-347F-4FBD-875E-B0610C16AE4E

Q29618915-8435F5AD-7A04-4091-8CBA-C71CB9689AE4

Q29618915-9D0852ED-B196-4298-A2FF-7B644F4E57AF

Q29618915-A0A7C9DF-DCE2-49CE-8343-B62B7D581140

Q29618915-A2CD6AB9-FBF6-4AC7-A8AA-A4C4327DE78C

Q29618915-E90C672E-A7F6-4B8C-B4E9-858CA4CF8379

P304

Q29618915-ADBA90B6-47BF-405E-A8BF-6094B8E48BE9

P31

Q29618915-9C8ED1E7-34FA-41BC-918D-CC45F2FD9198

P3181

Q29618915-64928DB2-591C-485D-9E0F-C93AC381C337

P356

Q29618915-14BBEAAA-DC60-49BD-A8EB-06B8880E15C4

P407

Q29618915-399FD018-E854-4728-8733-075B9D424EA0

P433

Q29618915-012C64C8-976C-4755-9FD5-4D71C1F6F2DC

P478

Q29618915-487C7ABA-DC01-41C8-BBEA-69E75E1897BA

P577

Q29618915-DEA14744-2E9F-4863-AC19-00D0C2C397F1

P698

Q29618915-C85B975F-3AB7-43AE-AF4B-1BD44E958258

P3181

P356

ARCHPSYC.1994.03950030035004

P1433

JAMA Psychiatry

P1476

Subanesthetic effects of the n ...... , and neuroendocrine responses

@en

P2093

Bowers MB Jr

http://www.w3.org/2001/XMLSchema#string

Bremner JD

http://www.w3.org/2001/XMLSchema#string

Charney DS

http://www.w3.org/2001/XMLSchema#string

Delaney R

http://www.w3.org/2001/XMLSchema#string

Freeman GK

http://www.w3.org/2001/XMLSchema#string

Heninger GR

http://www.w3.org/2001/XMLSchema#string

Karper LP

http://www.w3.org/2001/XMLSchema#string

Krystal JH

http://www.w3.org/2001/XMLSchema#string

Seibyl JP

http://www.w3.org/2001/XMLSchema#string

P304

199-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

426486

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/ARCHPSYC.1994.03950030035004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

1994-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8122957

http://www.w3.org/2001/XMLSchema#string